Liver and Immune System

Zakim and Boyer's Hepatology

Volumn , Issue , 2012, Pages 129-141

  Knolle, Percy ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882458770     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4377-0881-3.00009-7     Document Type: Chapter

References (301)

1. Ahmad N, et al. Regulation of cyclooxygenase-2 by nitric oxide in activated hepatic macrophages during acute endotoxemia. J Leukoc Biol 2002, 71:1005-1011. (Ref.59).
2. Albert ML, Jegathesan M, Darnell RB Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells. Nat Immunol 2001, 2:1010-1017.
3. Allan RS, et al. Epidermal viral immunity induced by CD8alpha+ dendritic cells but not by Langerhans cells. Science 2003, 301:1925-1928. (Ref.4).
4. Askenase PW, et al. Extravascular T-cell recruitment requires initiation begun by Valpha14+ NKT cells and B-1 B cells. Trends Immunol 2004, 25:441-449. (Ref.201).
5. Baron JL, et al. Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection. Immunity 2002, 16:583-594. (Ref.77).
6. Bashirova AA, et al. A dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN)-related protein is highly expressed on human liver sinusoidal endothelial cells and promotes HIV-1 infection. J Exp Med 2001, 193:671-678. (Ref.140).
7. Bertolino P, et al. Antigen-specific primary activation of CD8+ T cells within the liver. J Immunol 2001, 166:5430-5438. (Ref.158).
8. Bertolino P, et al. Early intrahepatic antigen-specific retention of naive CD8+ T cells is predominantly ICAM-1/LFA-1 dependent in mice. Hepatology 2005, 42:1063-1071. (Ref.141).
9. Bonder CS, et al. Rules of recruitment for Th1 and Th2 lymphocytes in inflamed liver: a role for alpha-4 integrin and vascular adhesion protein-1. Immunity 2005, 23:153-163. (Ref.143).
10. Bowen DG, et al. The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity. J Clin Invest 2004, 114:701-712. (Ref.200).
11. Breiner K, Schaller H, Knolle P Endothelial cell-mediated uptake of a hepatitis B virus: a new concept of liver-targeting of hepatotropic micro-organisms. Hepatology 2001, 34:803-808.
12. Breitkopf K, et al. Expression and matrix deposition of latent transforming growth factor beta binding proteins in normal and fibrotic rat liver and transdifferentiating hepatic stellate cells in culture. Hepatology 2001, 33:387-396. (Ref.131).
13. Brigl M, et al. Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat Immunol 2003, 4:1230-1237. (Ref.193).
14. Bykov I, et al. Phagocytosis and LPS-stimulated production of cytokines and prostaglandin E2 is different in Kupffer cells isolated from the periportal or perivenous liver region. Scand J Gastroenterol 2003, 38:1256-1261. (Ref.30).
15. Campos RA, et al. Cutaneous immunization rapidly activates liver invariant Valpha14 NKT cells stimulating B-1 B cells to initiate T cell recruitment for elicitation of contact sensitivity. J Exp Med 2003, 198:1785-1796. (Ref.198).
16. Castellaneta A, et al. NOD2 ligation subverts IFN-alpha production by liver plasmacytoid dendritic cells and inhibits their T cell allostimulatory activity via B7-H1 up-regulation. J Immunol 2009, 183:6922-6932. (Ref.118).
17. Clark SR, et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med 2007, 13:463-469. (Ref.188).
18. Cormier EG, et al. L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus. Proc Natl Acad Sci U S A 2004, 101:14067-14072. (Ref.88).
19. Crispe IN Hepatic T cells and liver tolerance. Nat Rev Immunol 2003, 3:51-62. (Ref.155).
20. Das A, et al. Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection. J Exp Med 2008, 205:2111-2124. (Ref.154).
21. De Creus A, et al. Low TLR4 expression by liver dendritic cells correlates with reduced capacity to activate allogeneic T cells in response to endotoxin. J Immunol 2005, 174:2037-2045. (Ref.117).
22. Diehl L, et al. Tolerogenic maturation of liver sinusoidal endothelial cells promotes B7-homolog 1-dependent CD8+ T cell tolerance. Hepatology 2008, 47:296-305. (Ref.184).
23. Dikopoulos N, et al. Type I IFN negatively regulates CD8+ T cell responses through IL-10-producing CD4+ T regulatory 1 cells. J Immunol 2005, 174:99-109. (Ref.164).
24. Dikopoulos N, et al. Recently primed CD8+ T cells entering the liver induce hepatocytes to interact with naive CD8+ T cells in the mouse. Hepatology 2004, 39:1256-1266. (Ref.157).
25. Emoto M, Kaufmann SH Liver NKT cells: an account of heterogeneity. Trends Immunol 2003, 24:364-369. (Ref.67).
26. Emoto M, et al. Participation of leukocyte function-associated antigen-1 and NK cells in the homing of thymic CD8+NKT cells to the liver. Eur J Immunol 2000, 30:3049-3056. (Ref.73).
27. Fischer K, et al. Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells. Proc Natl Acad Sci U S A 2004, 101:10685-10690. (Ref.189).
28. Gao B, Jeong WI, Tian Z Liver: an organ with predominant innate immunity. Hepatology 2008, 47:729-736. (Ref.186).
29. Geijtenbeek TB, et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000, 100:587-597. (Ref.89).
30. Geissmann F, et al. Intravascular immune surveillance by CXCR6+ NKT cells patrolling liver sinusoids. PLoS Biol 2005, 3:e113. (Ref.72).
31. Goddard S, et al. Interleukin-10 secretion differentiates dendritic cells from human liver and skin. Am J Pathol 2004, 164:511-519. (Ref.115).
32. Grant AJ, et al. Hepatic expression of secondary lymphoid chemokine (CCL21) promotes the development of portal-associated lymphoid tissue in chronic inflammatory liver disease. Am J Pathol 2002, 160:1445-1455. (Ref.119).
33. Gregory SH, Wing EJ Neutrophil-Kupffer cell interaction: a critical component of host defenses to systemic bacterial infections. J Leukoc Biol 2002, 72:239-248. (Ref.187).
34. Hemmi H, Akira S TLR signalling and the function of dendritic cells. Chem Immunol Allergy 2005, 86:120-135. (Ref.15).
35. Hoebe K, Janssen E, Beutler B The interface between innate and adaptive immunity. Nat Immunol 2004, 5:971-974. (Ref.14).
36. Holz LE, et al. Intrahepatic murine CD8 T-cell activation associates with a distinct phenotype leading to Bim-dependent death. Gastroenterology 2008, 135:989-997. (Ref.159).
37. Iwasaki A, Medzhitov R Regulation of adaptive immunity by the innate immune system. Science 2010, 327:291-295. (Ref.13).
38. Janssen EM, et al. CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes. Nature 2003, 421:852-856. (Ref.10).
39. Johansson AG, Sundqvist T, Skogh T IgG immune complex binding to and activation of liver cells. An in vitro study with IgG immune complexes, Kupffer cells, sinusoidal endothelial cells and hepatocytes. Int Arch Allergy Immunol 2000, 121:329-336. (Ref.97).
40. Johansson C, Wick MJ Liver dendritic cells present bacterial antigens and produce cytokines upon Salmonella encounter. J Immunol 2004, 172:2496-2503. (Ref.199).
41. John B, Crispe IN Passive and active mechanisms trap activated CD8+ T cells in the liver. J Immunol 2004, 172:5222-5229. (Ref.168).
42. Jomantaite I, et al. Hepatic dendritic cell subsets in the mouse. Eur J Immunol 2004, 34:355-365. (Ref.112).
43. Jonuleit H, et al. Dendritic cells as a tool to induce anergic and regulatory T cells. Trends Immunol 2001, 22:394-400. (Ref.197).
44. Kawai T, Akira S Innate immune recognition of viral infection. Nat Immunol 2006, 7:131-137. (Ref.11).
45. Kern M, et al. Virally infected mouse liver endothelial cells trigger CD8+ T-cell immunity. Gastroenterology 2010, 138:336-346. (Ref.195).
46. Khanna A, et al. Effects of liver-derived dendritic cell progenitors on Th1- and Th2-like cytokine responses in vitro and in vivo. J Immunol 2000, 164:1346-1354. (Ref.113).
47. Klein I, et al. Kupffer cell heterogeneity: functional properties of bone marrow derived and sessile hepatic macrophages. Blood 2007, 110:4077-4085. (Ref.22).
48. Knolle PA, Gerken G Local control of the immune response in the liver. Immunol Rev 2000, 174:21-34. (Ref.136).
49. Kronenberg M, Gapin L The unconventional lifestyle of NKT cells. Nat Rev Immunol 2002, 2:557-568. (Ref.65).
50. Laskin DL, Weinberger B, Laskin JD Functional heterogeneity in liver and lung macrophages. J Leukoc Biol 2001, 70:163-170. (Ref.38).
51. Lau AH, Thomson AW Dendritic cells and immune regulation in the liver. Gut 2003, 52:307-314. (Ref.111).
52. Lee WY, et al. An intravascular immune response to Borrelia burgdorferi involves Kupffer cells and iNKT cells. Nat Immunol 2010, 11:295-302. (Ref.25).
53. Lievens J, et al. The size of sinusoidal fenestrae is a critical determinant of hepatocyte transduction after adenoviral gene transfer. Gene Ther 2004, 11:1523-1531. (Ref.101).
54. Lopes AR, et al. Bim-mediated deletion of antigen-specific CD8 T cells in patients unable to control HBV infection. J Clin Invest 2008, 118:1835-1845. (Ref.160).
55. Lu L, et al. Liver-derived DEC205+B220+CD19-dendritic cells regulate T cell responses. J Immunol 2001, 166:7042-7052. (Ref.114).
56. Luth S, et al. Ectopic expression of neural autoantigen in mouse liver suppresses experimental autoimmune neuroinflammation by inducing antigen-specific Tregs. J Clin Invest 2008, 118:3403-3410. (Ref.161).
57. Lutz MB, Schuler G Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity?. Trends Immunol 2002, 23:445-449. (Ref.105).
58. Maher JJ Interactions between hepatic stellate cells and the immune system. Semin Liver Dis 2001, 21:417-426. (Ref.125).
59. Matsuno K, et al. Kupffer cell-mediated recruitment of dendritic cells to the liver crucial for a host defense. Dev Immunol 2002, 9:143-149. (Ref.75).
60. Mehal WZ, Azzaroli F, Crispe IN Antigen presentation by liver cells controls intrahepatic T cell trapping, whereas bone marrow-derived cells preferentially promote intrahepatic T cell apoptosis. J Immunol 2001, 167:667-673. (Ref.166).
61. Nakashima H, et al. Activation of mouse natural killer T cells accelerates liver regeneration after partial hepatectomy. Gastroenterology 2006, 131:1573-1583. (Ref.79).
62. Neuhuber WL, Tiegs G Innervation of immune cells: evidence for neuroimmunomodulation in the liver. Anat Rec 2004, 280A:884-892. (Ref.46).
63. Niess JH, et al. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 2005, 307:254-258. (Ref.3).
64. Notas G, Kisseleva T, Brenner D NK and NKT cells in liver injury and fibrosis. Clin Immunol 2009, 130:16-26. (Ref.80).
65. Oda M, Han JY, Yokomori H Local regulators of hepatic sinusoidal microcirculation: recent advances. Clin Hemorheol Microcirc 2000, 23:85-94. (Ref.82).
66. Paik YH, et al. Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. Hepatology 2003, 37:1043-1055. (Ref.129).
67. Pillarisetty VG, et al. Liver dendritic cells are less immunogenic than spleen dendritic cells because of differences in subtype composition. J Immunol 2004, 172:1009-1017. (Ref.110).
68. Politz O, et al. Stabilin-1 and -2 constitute a novel family of fasciclin-like hyaluronan receptor homologues. Biochem J 2002, 362:155-164. (Ref.92).
69. Probst HC, et al. Resting dendritic cells induce peripheral CD8(+) T cell tolerance through PD-1 and CTLA-4. Nat Immunol 2005, 6(3):280-286.
70. Rescigno M, et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2001, 2:361-367. (Ref.2).
71. Reynaert H, et al. Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension. Gut 2002, 50:571-581. (Ref.124).
72. Salazar-Mather TP, Lewis CA, Biron CA Type I interferons regulate inflammatory cell trafficking and macrophage inflammatory protein 1alpha delivery to the liver. J Clin Invest 2002, 110:321-330. (Ref.192).
73. Salio M, Silk JD, Cerundolo V Recent advances in processing and presentation of CD1 bound lipid antigens. Curr Opin Immunol 2010, 22:81-88. (Ref.66).
74. Schumann J, et al. Parenchymal, but not leukocyte, TNF receptor 2 mediates T cell-dependent hepatitis in mice. J Immunol 2003, 170:2129-2137. (Ref.48).
75. Schurich A, et al. Distinct kinetics and dynamics of cross-presentation in liver sinusoidal endothelial cells compared to dendritic cells. Hepatology 2009, 50:909-919. (Ref.183).
76. Seki E, Brenner DA Toll-like receptors and adaptor molecules in liver disease: update. Hepatology 2008, 48:322-335. (Ref.185).
77. Seki E, et al. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med 2007, 13:1324-1332. (Ref.132).
78. Shortman K, Liu YJ Mouse and human dendritic cell subtypes. Nat Rev Immunol 2002, 2:151-161. (Ref.1).
79. Sidobre S, et al. The T cell antigen receptor expressed by Valpha14i NKT cells has a unique mode of glycosphingolipid antigen recognition. Proc Natl Acad Sci U S A 2004, 101:12254-12259. (Ref.69).
80. Sixt M, et al. The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node. Immunity 2005, 22:19-29. (Ref.6).
81. Smedsrod B Clearance function of scavenger endothelial cells. Comp Hepatol 2004, 3(Suppl 1):S22. (Ref.84).
82. Steinman RM, et al. Dendritic cell function in vivo during the steady state: a role in peripheral tolerance. Ann N Y Acad Sci 2003, 987:15-25. (Ref.7).
83. Steinman RM, Hawiger D, Nussenzweig MC Tolerogenic dendritic cells. Annu Rev Immunol 2003, 21:685-711. (Ref.104).
84. Steptoe RJ, et al. Comparative analysis of dendritic cell density and total number in commonly transplanted organs: morphometric estimation in normal mice. Transpl Immunol 2000, 8:49-56. (Ref.109).
85. Swain MG Hepatic NKT cells: friend or foe?. Clin Sci (Lond) 2008, 114:457-466. (Ref.76).
86. Swann JB, et al. CD1-restricted T cells and tumor immunity. Curr Top Microbiol Immunol 2007, 314:293-323. (Ref.78).
87. Takeuchi O, Akira S MDA5/RIG-I and virus recognition. Curr Opin Immunol 2008, 20:17-22. (Ref.12).
88. Tanis W, et al. Human hepatic lymph nodes contain normal numbers of mature myeloid dendritic cells but few plasmacytoid dendritic cells. Clin Immunol 2004, 110:81-88. (Ref.122).
89. Trobonjaca Z, et al. Activating immunity in the liver. II. IFN-beta attenuates NK cell-dependent liver injury triggered by liver NKT cell activation. J Immunol 2002, 168:3763-3770. (Ref.163).
90. Trobonjaca Z, et al. Activating immunity in the liver. I. Liver dendritic cells (but not hepatocytes) are potent activators of IFN-gamma release by liver NKT cells. J Immunol 2001, 167:1413-1422. (Ref.190).
91. van Oosten M, et al. Scavenger receptor-like receptors for the binding of lipopolysaccharide and lipoteichoic acid to liver endothelial and Kupffer cells. J Endotoxin Res 2001, 7:381-384. (Ref.26).
92. Vazquez-Torres A, et al. Toll-like receptor 4 dependence of innate and adaptive immunity to Salmonella: importance of the Kupffer cell network. J Immunol 2004, 172:6202-6208. (Ref.47).
93. Vinas O, et al. Human hepatic stellate cells show features of antigen-presenting cells and stimulate lymphocyte proliferation. Hepatology 2003, 38:919-929. (Ref.126).
94. Vincent MS, et al. CD1-dependent dendritic cell instruction. Nat Immunol 2002, 3:1163-1168. (Ref.194).
95. von Oppen N, et al. Systemic antigen cross-presented by liver sinusoidal endothelial cells induces liver-specific CD8 T-cell retention and tolerization. Hepatology 2009, 49:1664-1672. (Ref.142).
96. Wahl C, et al. B7-H1 on hepatocytes facilitates priming of specific CD8 T cells but limits the specific recall of primed responses. Gastroenterology 2008, 135:980-988. (Ref.156).
97. Winau F, et al. Ito cells are liver-resident antigen-presenting cells for activating T cell responses. Immunity 2007, 26:117-129. (Ref.127).
98. Winau F, Quack C, Darmoise A, Kaufmann SH Starring stellate cells in liver immunology. Curr Opin Immunol 2008, 20:68-74. (Ref.128).
99. Wu D, et al. Bacterial glycolipids and analogs as antigens for CD1d-restricted NKT cells. Proc Natl Acad Sci U S A 2005, 102:1351-1356. (Ref.68).
100. You Q, et al. Mechanism of T cell tolerance induction by murine hepatic Kupffer cells. Hepatology 2008, 48:978-990. (Ref.169).
101. Shortman K, Liu YJ Mouse and human dendritic cell subtypes. Nat Rev Immunol 2002, 2:151-161.
102. Rescigno M, et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2001, 2:361-367.
103. Niess JH, et al. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 2005, 307:254-258.
104. Allan RS, et al. Epidermal viral immunity induced by CD8alpha+ dendritic cells but not by Langerhans cells. Science 2003, 301:1925-1928.
105. Gutgemann I, et al. Induction of rapid T cell activation and tolerance by systemic presentation of an orally administered antigen. Immunity 1998, 8:667-673.
106. Sixt M, et al. The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node. Immunity 2005, 22:19-29.
107. Steinman RM, et al. Dendritic cell function in vivo during the steady state: a role in peripheral tolerance. Ann N Y Acad Sci 2003, 987:15-25.
108. Probst HC, et al. Resting dendritic cells induce peripheral CD8(+) T cell tolerance through PD-1 and CTLA-4. Nat Immunol 2005, 6(3):280-286.
109. Albert ML, Jegathesan M, Darnell RB Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells. Nat Immunol 2001, 2:1010-1017.
110. Janssen EM, et al. CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes. Nature 2003, 421:852-856.
111. Kawai T, Akira S Innate immune recognition of viral infection. Nat Immunol 2006, 7:131-137.
112. Takeuchi O, Akira S MDA5/RIG-I and virus recognition. Curr Opin Immunol 2008, 20:17-22.
113. Iwasaki A, Medzhitov R Regulation of adaptive immunity by the innate immune system. Science 2010, 327:291-295.
114. Hoebe K, Janssen E, Beutler B The interface between innate and adaptive immunity. Nat Immunol 2004, 5:971-974.
115. Hemmi H, Akira S TLR signalling and the function of dendritic cells. Chem Immunol Allergy 2005, 86:120-135.
116. Jacob AI, et al. Endotoxin and bacteria in portal blood. Gastroenterology 1977, 72:1268-1270.
117. Lumsden AB, Henderson JM, Kutner MH Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis. Hepatology 1988, 8:232-236.
118. Blouin A, Bolender RP, Weibel ER Distribution of organelles and membranes between hepatocytes and nonhepatocytes in the rat liver parenchyma. A stereological study. J Cell Biol 1977, 72:441-455.
119. Wake K, et al. Cell biology and kinetics of Kupffer cells in the liver. Int Rev Cytol 1989, 118:173-229.
120. Gale RP, Sparkes RS, Golde DW Bone marrow origin of hepatic macrophages (Kupffer cells) in humans. Science 1978, 201:937-938.
121. Bouwens L, et al. Quantitation, tissue distribution and proliferation kinetics of Kupffer cells in normal rat liver. Hepatology 1986, 6:718-722.
122. Klein I, et al. Kupffer cell heterogeneity: functional properties of bone marrow derived and sessile hepatic macrophages. Blood 2007, 110:4077-4085.
123. Yamada M, Naito M, Takahashi K Kupffer cell proliferation and glucan-induced granuloma formation in mice depleted of blood monocytes by strontium-89. J Leukoc Biol 1990, 47:195-205.
124. Yamamoto T, et al. Repopulation of murine Kupffer cells after intravenous administration of liposome-encapsulated dichloromethylene diphosphonate. Am J Pathol 1996, 149:1271-1286.
125. Lee WY, et al. An intravascular immune response to Borrelia burgdorferi involves Kupffer cells and iNKT cells. Nat Immunol 2010, 11:295-302.
126. van Oosten M, et al. Scavenger receptor-like receptors for the binding of lipopolysaccharide and lipoteichoic acid to liver endothelial and Kupffer cells. J Endotoxin Res 2001, 7:381-384.
127. Roh MS, et al. Human Kupffer cells are cytotoxic against human colon adenocarcinoma. Surgery 1990, 108:400-404. discussion 404-405.
128. Falasca L, et al. Human Kupffer cell recognition and phagocytosis of apoptotic peripheral blood lymphocytes. Exp Cell Res 1996, 224:152-162.
129. van Oosten M, et al. New scavenger receptor-like receptors for the binding of lipopolysaccharide to liver endothelial and Kupffer cells. Infect Immun 1998, 66:5107-5112.
130. Bykov I, et al. Phagocytosis and LPS-stimulated production of cytokines and prostaglandin E2 is different in Kupffer cells isolated from the periportal or perivenous liver region. Scand J Gastroenterol 2003, 38:1256-1261.
131. Sleyster EC, Knook DL Relation between localization and function of rat liver Kupffer cells. Lab Invest 1982, 47:484-490.
132. Itoh Y, et al. Functional heterogeneity of rat liver macrophages: interleukin-1 secretion and Ia antigen expression in contrast with phagocytic activity. Liver 1992, 12:26-33.
133. Rogoff TM, Lipsky PE Antigen presentation by isolated guinea pig Kupffer cells. J Immunol 1980, 124:1740-1744.
134. Richman LK, et al. The murine Kupffer cell. I. Characterization of the cell serving accessory function in antigen-specific T cell proliferation. J Immunol 1979, 123:2602-2609.
135. Rubinstein D, Roska AK, Lipsky PE Liver sinusoidal lining cells express class II major histocompatibility antigens but are poor stimulators of fresh allogeneic T lymphocytes. J Immunol 1986, 137:1803-1810.
136. Rubinstein D, Roska AK, Lipsky PE Antigen presentation by liver sinusoidal lining cells after antigen exposure in vivo. J Immunol 1987, 138:1377-1382.
137. Winwood PJ, Arthur MJ Kupffer cells: their activation and role in animal models of liver injury and human liver disease. Semin Liver Dis 1993, 13:50-59.
138. Laskin DL, Weinberger B, Laskin JD Functional heterogeneity in liver and lung macrophages. J Leukoc Biol 2001, 70:163-170.
139. Lichtman SN, Wang J, Lemasters JJ LPS receptor CD14 participates in release of TNF-alpha in RAW 264.7 and peritoneal cells but not in Kupffer cells. Am J Physiol 1998, 275:G39-G46.
140. Callery MP, Mangino MJ, Flye MW A biologic basis for limited Kupffer cell reactivity to portal-derived endotoxin. Surgery 1991, 110:221-230.
141. Lepay DA, et al. Murine Kupffer cells. Mononuclear phagocytes deficient in the generation of reactive oxygen intermediates. J Exp Med 1985, 161:1079-1096.
142. Hafenrichter DG, et al. The Kupffer cell in endotoxin tolerance: mechanisms of protection against lethal endotoxemia. Shock 1994, 2:251-256.
143. Knolle P, et al. Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS) challenge. J Hepatol 1995, 22:226-229.
144. Knolle PA, et al. Regulation of endotoxin-induced IL-6 production in liver sinusoidal endothelial cells and Kupffer cells by IL-10. Clin Exp Immunol 1997, 107:555-561.
145. van der Poll T, et al. Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia. J Clin Invest 1996, 97:713-719.
146. Neuhuber WL, Tiegs G Innervation of immune cells: evidence for neuroimmunomodulation in the liver. Anat Rec 2004, 280A:884-892.
147. Vazquez-Torres A, et al. Toll-like receptor 4 dependence of innate and adaptive immunity to Salmonella: importance of the Kupffer cell network. J Immunol 2004, 172:6202-6208.
148. Schumann J, et al. Parenchymal, but not leukocyte, TNF receptor 2 mediates T cell-dependent hepatitis in mice. J Immunol 2003, 170:2129-2137.
149. Decker K Biologically active products of stimulated liver macrophages (Kupffer cells). Eur J Biochem 1990, 192:245-261.
150. Shirahama M, et al. Kinetics and parameters of the induction of interleukin 1 secretion by rat Kupffer cells. J Clin Lab Immunol 1988, 27:127-132.
151. Shirahama M, et al. Kupffer cells may autoregulate interleukin 1 production by producing interleukin 1 inhibitor and prostaglandin E2. Scand J Immunol 1988, 28:719-725.
152. Busam KJ, et al. Interleukin-6 release by rat liver macrophages. J Hepatol 1990, 11:367-373.
153. Takahashi M, et al. LPS induces NK1.1+ alpha beta T cells with potent cytotoxicity in the liver of mice via production of IL-12 from Kupffer cells. J Immunol 1996, 156:2436-2442.
154. Okamura H, et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 1995, 378:88-91.
155. Karck U, Peters T, Decker K The release of tumor necrosis factor from endotoxin-stimulated rat Kupffer cells is regulated by prostaglandin E2 and dexamethasone. J Hepatol 1988, 7:352-361.
156. Bissell DM, et al. Cell-specific expression of transforming growth factor-beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation. J Clin Invest 1995, 96:447-455.
157. Meyer DH, Bachem MG, Gressner AM Modulation of hepatic lipocyte proteoglycan synthesis and proliferation by Kupffer cell-derived transforming growth factors type beta 1 and type alpha. Biochem Biophys Res Commun 1990, 171:1122-1129.
158. Bautista AP, Spitzer JJ Superoxide anion generation by in situ perfused rat liver: effect of in vivo endotoxin. Am J Physiol 1990, 259:G907-G912.
159. Ahmad N, et al. Regulation of cyclooxygenase-2 by nitric oxide in activated hepatic macrophages during acute endotoxemia. J Leukoc Biol 2002, 71:1005-1011.
160. van Oosten M, et al. Vascular adhesion molecule-1 and intercellular adhesion molecule-1 expression on rat liver cells after lipopolysaccharide administration in vivo. Hepatology 1995, 22:1538-1546.
161. Matsuura K, et al. Upregulation of mouse CD14 expression in Kupffer cells by lipopolysaccharide. J Exp Med 1994, 179:1671-1676.
162. Myers KJ, et al. Interleukin-12-induced adhesion molecule expression in murine liver. Am J Pathol 1998, 152:457-468.
163. Burgio VL, et al. Expression of co-stimulatory molecules by Kupffer cells in chronic hepatitis of hepatitis C virus etiology. Hepatology 1998, 27:1600-1606.
164. Lohse AW, et al. Antigen-presenting function and B7 expression of murine sinusoidal endothelial cells and Kupffer cells. Gastroenterology 1996, 110:1175-1181.
165. Kronenberg M, Gapin L The unconventional lifestyle of NKT cells. Nat Rev Immunol 2002, 2:557-568.
166. Salio M, Silk JD, Cerundolo V Recent advances in processing and presentation of CD1 bound lipid antigens. Curr Opin Immunol 2010, 22:81-88.
167. Emoto M, Kaufmann SH Liver NKT cells: an account of heterogeneity. Trends Immunol 2003, 24:364-369.
168. Wu D, et al. Bacterial glycolipids and analogs as antigens for CD1d-restricted NKT cells. Proc Natl Acad Sci U S A 2005, 102:1351-1356.
169. Sidobre S, et al. The T cell antigen receptor expressed by Valpha14i NKT cells has a unique mode of glycosphingolipid antigen recognition. Proc Natl Acad Sci U S A 2004, 101:12254-12259.
170. Ohteki T, et al. Cutting edge: LFA-1 is required for liver NK1.1+TCR alpha beta+ cell development: evidence that liver NK1.1+TCR alpha beta+ cells originate from multiple pathways. J Immunol 1999, 162:3753-3756.
171. Emoto M, et al. Critical role of leukocyte function-associated antigen-1 in liver accumulation of CD4+NKT cells. J Immunol 1999, 162:5094-5098.
172. Geissmann F, et al. Intravascular immune surveillance by CXCR6+ NKT cells patrolling liver sinusoids. PLoS Biol 2005, 3:e113.
173. Emoto M, et al. Participation of leukocyte function-associated antigen-1 and NK cells in the homing of thymic CD8+NKT cells to the liver. Eur J Immunol 2000, 30:3049-3056.
174. Vanderkerken K, et al. The role of Kupffer cells in the differentiation process of hepatic natural killer cells. Hepatology 1995, 22:283-290.
175. Matsuno K, et al. Kupffer cell-mediated recruitment of dendritic cells to the liver crucial for a host defense. Dev Immunol 2002, 9:143-149.
176. Swain MG Hepatic NKT cells: friend or foe?. Clin Sci (Lond) 2008, 114:457-466.
177. Baron JL, et al. Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection. Immunity 2002, 16:583-594.
178. Swann JB, et al. CD1-restricted T cells and tumor immunity. Curr Top Microbiol Immunol 2007, 314:293-323.
179. Nakashima H, et al. Activation of mouse natural killer T cells accelerates liver regeneration after partial hepatectomy. Gastroenterology 2006, 131:1573-1583.
180. Notas G, Kisseleva T, Brenner D NK and NKT cells in liver injury and fibrosis. Clin Immunol 2009, 130:16-26.
181. Wisse E, et al. The liver sieve: considerations concerning the structure and function of endothelial fenestrae, the sinusoidal wall and the space of Disse. Hepatology 1985, 5:683-692.
182. Oda M, Han JY, Yokomori H Local regulators of hepatic sinusoidal microcirculation: recent advances. Clin Hemorheol Microcirc 2000, 23:85-94.
183. Steffan AM, et al. Phagocytosis, an unrecognized property of murine endothelial liver cells. Hepatology 1986, 6:830-836.
184. Smedsrod B Clearance function of scavenger endothelial cells. Comp Hepatol 2004, 3(Suppl 1):S22.
185. Tavassoli M, et al. Liver endothelium mediates the uptake of iron-transferrin complex by hepatocytes. Exp Cell Res 1986, 165:369-379.
186. Tavassoli M, Kishimoto T, Kataoka M Liver endothelium mediates the hepatocyte's uptake of ceruloplasmin. J Cell Biol 1986, 102:1298-1303.
187. Breiner K, Schaller H, Knolle P Endothelial cell-mediated uptake of a hepatitis B virus: a new concept of liver-targeting of hepatotropic micro-organisms. Hepatology 2001, (in press).
188. Cormier EG, et al. L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus. Proc Natl Acad Sci U S A 2004, 101:14067-14072.
189. Geijtenbeek TB, et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000, 100:587-597.
190. Smedsrod B, et al. Advanced glycation end products are eliminated by scavenger-receptor-mediated endocytosis in hepatic sinusoidal Kupffer and endothelial cells. Biochem J 1997, 322:567-573.
191. Smedsrod B, et al. Studies in vitro on the uptake and degradation of sodium hyaluronate in rat liver endothelial cells. Biochem J 1984, 223:617-626.
192. Politz O, et al. Stabilin-1 and -2 constitute a novel family of fasciclin-like hyaluronan receptor homologues. Biochem J 2002, 362:155-164.
193. Van Berkel TJ, De Rijke YB, Kruijt JK Different fate in vivo of oxidatively modified low density lipoprotein and acetylated low density lipoprotein in rats. Recognition by various scavenger receptors on Kupffer and endothelial liver cells. J Biol Chem 1991, 266:2282-2289.
194. Smedsrod B, et al. Scavenger functions of the liver endothelial cell. Biochem J 1990, 266:313-327.
195. Melkko J, et al. Clearance of NH2-terminal propeptides of types I and III procollagen is a physiological function of the scavenger receptor in liver endothelial cells. J Exp Med 1994, 179:405-412.
196. Skogh T, et al. Hepatic uptake of circulating IgG immune complexes. Immunology 1985, 55:585-594.
197. Johansson AG, Sundqvist T, Skogh T IgG immune complex binding to and activation of liver cells. An in vitro study with IgG immune complexes, Kupffer cells, sinusoidal endothelial cells and hepatocytes. Int Arch Allergy Immunol 2000, 121:329-336.
198. Fraser R, et al. Nicotine decreases the porosity of the rat liver sieve: a possible mechanism for hypercholesterolaemia. Br J Exp Pathol 1988, 69:345-350.
199. Sanan DA, et al. Hepatic lipase is abundant on both hepatocyte and endothelial cell surfaces in the liver. J Lipid Res 1997, 38:1002-1013.
200. Fraser R, Dobbs BR, Rogers GW Lipoproteins and the liver sieve: the role of the fenestrated sinusoidal endothelium in lipoprotein metabolism, atherosclerosis, and cirrhosis. Hepatology 1995, 21:863-874.
201. Lievens J, et al. The size of sinusoidal fenestrae is a critical determinant of hepatocyte transduction after adenoviral gene transfer. Gene Ther 2004, 11:1523-1531.
202. Kempka G, Kolb-Bachofen V Binding, uptake, and transcytosis of ligands for mannose-specific receptors in rat liver: an electron microscopic study. Exp Cell Res 1988, 176:38-48.
203. McNab G, et al. Vascular adhesion protein 1 mediates binding of T cells to human hepatic endothelium. Gastroenterology 1996, 110:522-528.
204. Steinman RM, Hawiger D, Nussenzweig MC Tolerogenic dendritic cells. Annu Rev Immunol 2003, 21:685-711.
205. Lutz MB, Schuler G Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity?. Trends Immunol 2002, 23:445-449.
206. Matsuno K, et al. A life stage of particle-laden rat dendritic cells in vivo: their terminal division, active phagocytosis, and translocation from the liver to the draining lymph. J Exp Med 1996, 183:1865-1878. (see comments).
207. Kudo S, et al. A novel migration pathway for rat dendritic cells from the blood: hepatic sinusoids-lymph translocation. J Exp Med 1997, 185:777-784.
208. Sato T, et al. Maturation of rat dendritic cells during intrahepatic translocation evaluated using monoclonal antibodies and electron microscopy. Cell Tissue Res 1998, 294:503-514.
209. Steptoe RJ, Patel RK, Subbotin VM, Thomson AW Comparative analysis of dendritic cell density and total number in commonly transplanted organs: morphometric estimation in normal mice. Transpl Immunol 2000, 8:49-56.
210. Pillarisetty VG, et al. Liver dendritic cells are less immunogenic than spleen dendritic cells because of differences in subtype composition. J Immunol 2004, 172:1009-1017.
211. Lau AH, Thomson AW Dendritic cells and immune regulation in the liver.
212. Jomantaite I, et al. Hepatic dendritic cell subsets in the mouse. Eur J Immunol 2004, 34:355-365.
213. Khanna A, et al. Effects of liver-derived dendritic cell progenitors on Th1- and Th2-like cytokine responses in vitro and in vivo. J Immunol 2000, 164:1346-1354.
214. Lu L, et al. Liver-derived DEC205+B220+CD19-dendritic cells regulate T cell responses. J Immunol 2001, 166:7042-7052.
215. Goddard S, et al. Interleukin-10 secretion differentiates dendritic cells from human liver and skin. Am J Pathol 2004, 164:511-519.
216. Qian S, et al. Donor pretreatment with Flt-3 ligand augments antidonor cytotoxic T lymphocyte, natural killer, and lymphokine-activated killer cell activities within liver allografts and alters the pattern of intragraft apoptotic activity. Transplantation 1998, 65:1590-1598.
217. De Creus A, et al. Low TLR4 expression by liver dendritic cells correlates with reduced capacity to activate allogeneic T cells in response to endotoxin. J Immunol 2005, 174:2037-2045.
218. Castellaneta A, et al. NOD2 ligation subverts IFN-alpha production by liver plasmacytoid dendritic cells and inhibits their T cell allostimulatory activity via B7-H1 up-regulation. J Immunol 2009, 183:6922-6932.
219. Grant AJ, et al. Hepatic expression of secondary lymphoid chemokine (CCL21) promotes the development of portal-associated lymphoid tissue in chronic inflammatory liver disease. Am J Pathol 2002, 160:1445-1455.
220. Cyster JG Chemokines and the homing of dendritic cells to the T cell areas of lymphoid organs. J Exp Med 1999, 189:447-450.
221. Forster R, et al. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 1999, 99:23-33.
222. Tanis W, et al. Human hepatic lymph nodes contain normal numbers of mature myeloid dendritic cells but few plasmacytoid dendritic cells. Clin Immunol 2004, 110:81-88.
223. Friedman SL Hepatic stellate cells. Prog Liver Dis 1996, 14:101-130.
224. Reynaert H, et al. Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension. Gut 2002, 50:571-581.
225. Maher JJ Interactions between hepatic stellate cells and the immune system. Semin Liver Dis 2001, 21:417-426.
226. Vinas O, et al. Human hepatic stellate cells show features of antigen-presenting cells and stimulate lymphocyte proliferation. Hepatology 2003, 38:919-929.
227. Winau F, et al. Ito cells are liver-resident antigen-presenting cells for activating T cell responses. Immunity 2007, 26:117-129.
228. Winau F, et al. Starring stellate cells in liver immunology. Curr Opin Immunol 2008, 20:68-74.
229. Paik YH, et al. Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. Hepatology 2003, 37:1043-1055.
230. Wang SC, et al. Expression of interleukin-10 by in vitro and in vivo activated hepatic stellate cells. J Biol Chem 1998, 273:302-308.
231. Breitkopf K, et al. Expression and matrix deposition of latent transforming growth factor beta binding proteins in normal and fibrotic rat liver and transdifferentiating hepatic stellate cells in culture. Hepatology 2001, 33:387-396.
232. Seki E, et al. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med 2007, 13:1324-1332.
233. Hellerbrand S, et al. Expression of intracellular adhesion molecule 1 by activated hepatic stellate cells. Hepatology 1996, 24:670-676.
234. Knittel T, et al. Expression and regulation of cell adhesion molecules by hepatic stellate cells (HSC) of rat liver: involvement of HSC in recruitment of inflammatory cells during hepatic tissue repair. Am J Pathol 1999, 154:153-167.
235. Knittel T, et al. Cell-type-specific expression of neural cell adhesion molecule (N-CAM) in Ito cells of rat liver. Up-regulation during in vitro activation and in hepatic tissue repair. Am J Pathol 1996, 149:449-462.
236. Knolle PA, Gerken G Local control of the immune response in the liver. Immunol Rev 2000, 174:21-34.
237. McCuskey RS, Reilly FD Hepatic microvasculature: dynamic structure and its regulation. Semin Liver Dis 1993, 13:1-12.
238. Essani NA, et al. Endotoxin-induced activation of the nuclear transcription factor kappa B and expression of E-selectin messenger RNA in hepatocytes, Kupffer cells, and endothelial cells in vivo. J Immunol 1996, 156:2956-2963.
239. Wong J, et al. A minimal role for selectins in the recruitment of leukocytes into the inflamed liver microvasculature. J Clin Invest 1997, 99:2782-2790.
240. Bashirova AA, et al. A dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN)-related protein is highly expressed on human liver sinusoidal endothelial cells and promotes HIV-1 infection. J Exp Med 2001, 193:671-678.
241. Bertolino P, et al. Early intrahepatic antigen-specific retention of naive CD8+ T cells is predominantly ICAM-1/LFA-1 dependent in mice. Hepatology 2005, 42:1063-1071.
242. von Oppen N, et al. Systemic antigen cross-presented by liver sinusoidal endothelial cells induces liver-specific CD8 T-cell retention and tolerization. Hepatology 2009, 49:1664-1672.
243. Bonder CS, et al. Rules of recruitment for Th1 and Th2 lymphocytes in inflamed liver: a role for alpha-4 integrin and vascular adhesion protein-1. Immunity 2005, 23:153-163.
244. Calne RY Induction of immunological tolerance by porcine liver allografts. Nature 1969, 223:472-476.
245. Cantor H, Dumont A Hepatic suppression of sensitization to antigen absorbed into the portal system. Nature 1967, 215:744-745.
246. Dahmen U, Qian S, Rao AS, Demetris AJ, et al. Split tolerance induced by orthotopic liver transplantation in mice. Transplantation 1994, 58:1-8.
247. Barker CF, Corriere JN Canine renal homotransplantation with venous drainage via the portal vein. Ann Surg 1967, 165:279-282.
248. Boeckx W, et al. Prolongation of allogeneic heart graft survival in the rat after implantation on portal vein. Transplantation 1975, 19:145-149.
249. Gorczynski RM, et al. Prolongation of rat small bowel or renal allograft survival by pretransplant transfusion and/or by varying the route of allograft venous drainage. Transplantation 1994, 58:816-820.
250. May AG, et al. Survival of allografts after hepatic portal venous administration of specific transplantation antigen. Ann Surg 1969, 170:824-832.
251. Rieder H, et al. Prostanoid release of cultured liver sinusoidal endothelial cells in response to endotoxin and tumor necrosis factor. Comparison with umbilical vein endothelial cells. J Hepatol 1990, 11:359-366.
252. Kuiper J, et al. Identification of prostaglandin D2 as the major eicosanoid from liver endothelial and Kupffer cells. Biochim Biophys Acta 1988, 959:143-152.
253. Steinbrink K, et al. Induction of tolerance by IL-10-treated dendritic cells. J Immunol 1997, 159:4772-4780.
254. Das A, et al. Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection. J Exp Med 2008, 205:2111-2124.
255. Crispe IN Hepatic T cells and liver tolerance. Nat Rev Immunol 2003, 3:51-62.
256. Wahl C, et al. B7-H1 on hepatocytes facilitates priming of specific CD8 T cells but limits the specific recall of primed responses. Gastroenterology 2008, 135:980-988.
257. Dikopoulos N, et al. Recently primed CD8+ T cells entering the liver induce hepatocytes to interact with naive CD8+ T cells in the mouse. Hepatology 2004, 39:1256-1266.
258. Bertolino P, et al. Antigen-specific primary activation of CD8+ T cells within the liver. J Immunol 2001, 166:5430-5438.
259. Holz LE, et al. Intrahepatic murine CD8 T-cell activation associates with a distinct phenotype leading to Bim-dependent death. Gastroenterology 2008, 135:989-997.
260. Lopes AR, et al. Bim-mediated deletion of antigen-specific CD8 T cells in patients unable to control HBV infection. J Clin Invest 2008, 118:1835-1845.
261. Luth S, et al. Ectopic expression of neural autoantigen in mouse liver suppresses experimental autoimmune neuroinflammation by inducing antigen-specific Tregs. J Clin Invest 2008, 118:3403-3410.
262. Gorczynski L, et al. Evidence that an OX-2-positive cell can inhibit the stimulation of type 1 cytokine production by bone marrow-derived B7-1 (and B7-2)-positive dendritic cells. J Immunol 1999, 162:774-781.
263. Trobonjaca Z, et al. Activating immunity in the liver. I. IFN-beta attenuates NK cell-dependent liver injury triggered by liver NKT cell activation. J Immunol 2002, 168:3763-3770.
264. Dikopoulos N, et al. Type I IFN negatively regulates CD8+ T cell responses through IL-10-producing CD4+ T regulatory 1 cells. J Immunol 2005, 174:99-109.
265. Huang L, et al. The liver eliminates T cells undergoing antigen-triggered apoptosis in vivo. Immunity 1994, 1:741-749.
266. Mehal WZ, Azzaroli F, Crispe IN Antigen presentation by liver cells controls intrahepatic T cell trapping, whereas bone marrow-derived cells preferentially promote intrahepatic T cell apoptosis. J Immunol 2001, 167:667-673.
267. Mehal WZ, Juedes AE, Crispe IN Selective retention of activated CD8+ T cells by the normal liver. J Immunol 1999, 163:3202-3210.
268. John B, Crispe IN Passive and active mechanisms trap activated CD8+ T cells in the liver. J Immunol 2004, 172:5222-5229.
269. You Q, et al. Mechanism of T cell tolerance induction by murine hepatic Kupffer cells. Hepatology 2008, 48:978-990.
270. Knolle PA, et al. Induction of cytokine production in naive CD4(+) T cells by antigen-presenting murine liver sinusoidal endothelial cells but failure to induce differentiation toward Th1 cells. Gastroenterology 1999, 116:1428-1440.
271. Cella M, Sallusto F, Lanzavecchia A Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 1997, 9:10-16.
272. Cunningham AC, et al. A comparison of the antigen-presenting capabilities of class II MHC-expressing human lung epithelial and endothelial cells. Immunology 1997, 91:458-463.
273. Haraldsen G, et al. Major histocompatibility complex class II-dependent antigen presentation by human intestinal endothelial cells. Gastroenterology 1998, 114:649-656.
274. Marelli-Berg FM, et al. Major histocompatibility complex class II-expressing endothelial cells induce allospecific nonresponsiveness in naive T cells. J Exp Med 1996, 183:1603-1612.
275. Rehermann B Immunopathogenesis of viral hepatitis. Baillieres Clin Gastroenterol 1996, 10:483-500.
276. Ma W, Pober JS Human endothelial cells effectively costimulate cytokine production by, but not differentiation of, naive CD4+ T cells. J Immunol 1998, 161:2158-2167.
277. Gorczynski RM Adoptive transfer of unresponsiveness to allogeneic skin grafts with hepatic gamma delta+ T cells. Immunology 1994, 81:27-35.
278. Bevan MJ Interaction antigens detected by cytotoxic T cells with the major histocompatibility complex as modifier. Nature 1975, 256:419-421.
279. Heath WR, et al. Cross-tolerance: a pathway for inducing tolerance to peripheral tissue antigens. J Exp Med 1998, 187:1549-1553.
280. Kurts C Cross-presentation: inducing CD8 T cell immunity and tolerance. J Mol Med 2000, 78:326-332.
281. Sigal LJ, et al. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen. Nature 1999, 398:77-80.
282. Limmer A, et al. Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance. Nat Med 2000, 6:1348-1354.
283. Schurich A, et al. Distinct kinetics and dynamics of cross-presentation in liver sinusoidal endothelial cells compared to dendritic cells. Hepatology 2009, 50:909-919.
284. Diehl L, et al. Tolerogenic maturation of liver sinusoidal endothelial cells promotes B7-homolog 1-dependent CD8+ T cell tolerance. Hepatology 2008, 47:296-305.
285. Seki E, Brenner DA Toll-like receptors and adaptor molecules in liver disease: update. Hepatology 2008, 48:322-335.
286. Gao B, Jeong WI, Tian Z Liver: an organ with predominant innate immunity. Hepatology 2008, 47:729-736.
287. Gregory SH, Wing EJ Neutrophil-Kupffer cell interaction: a critical component of host defenses to systemic bacterial infections. J Leukoc Biol 2002, 72:239-248.
288. Clark SR, et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med 2007, 13:463-469.
289. Fischer K, et al. Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells. Proc Natl Acad Sci U S A 2004, 101:10685-10690.
290. Trobonjaca Z, et al. Activating immunity in the liver. I. Liver dendritic cells (but not hepatocytes) are potent activators of IFN-gamma release by liver NKT cells. J Immunol 2001, 167:1413-1422.
291. Salazar-Mather TP, Hamilton TA, Biron CA A chemokine-to-cytokine-to-chemokine cascade critical in antiviral defense. J Clin Invest 2000, 105:985-993.
292. Salazar-Mather TP, Lewis CA, Biron CA Type I interferons regulate inflammatory cell trafficking and macrophage inflammatory protein 1alpha delivery to the liver. J Clin Invest 2002, 110:321-330.
293. Brigl M, et al. Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat Immunol 2003, 4:1230-1237.
294. Vincent MS, et al. CD1-dependent dendritic cell instruction. Nat Immunol 2002, 3:1163-1168.
295. Kern M, et al. Virally infected mouse liver endothelial cells trigger CD8+ T-cell immunity. Gastroenterology 2010, 138:336-346.
296. Groux H, et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997, 389:737-742.
297. Jonuleit H, et al. Dendritic cells as a tool to induce anergic and regulatory T cells. Trends Immunol 2001, 22:394-400.
298. Campos RA, et al. Cutaneous immunization rapidly activates liver invariant Valpha14 NKT cells stimulating B-1 B cells to initiate T cell recruitment for elicitation of contact sensitivity. J Exp Med 2003, 198:1785-1796.
299. Johansson C, Wick MJ Liver dendritic cells present bacterial antigens and produce cytokines upon Salmonella encounter. J Immunol 2004, 172:2496-2503.
300. Bowen DG, et al. The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity. J Clin Invest 2004, 114:701-712.
301. Askenase PW, et al. Extravascular T-cell recruitment requires initiation begun by Valpha14+ NKT cells and B-1 B cells. Trends Immunol 2004, 25:441-449.